| 刘志磊,李洁,高恩明,李小芳,杨建红,张辉.以部分疫苗为例分析我国预防用生物制品的改良情况[J].中国药事,2020,34(1):1-4 |
| 以部分疫苗为例分析我国预防用生物制品的改良情况 |
| Analysis of the Improvement of Biological Products for Prevention in China Taking Some Vaccines as an Example |
| 投稿时间：2019-10-29 |
| DOI：10.16153/j.1002-7777.2020.01.001 |
| 中文关键词: 疫苗 技术改良 监管 百日咳疫苗 人用狂犬病疫苗 政策 |
| 英文关键词: vaccine technical improvement regulatory pertussis vaccine human rabies vaccine policies |
| 基金项目: |
|
| 摘要点击次数: 1470 |
| 全文下载次数: 335 |
| 中文摘要: |
| 目的：以百日咳疫苗、人用狂犬病疫苗的改良情况为例，分析监管政策对预防用生物制品技术改良的影响。方法：通过数据分析和文献研究，对我国已批准疫苗的技术改良情况进行分析。结果：技术改良是促进疫苗产业发展的重要手段。结论：监管机构需要通过政策的引导和鼓励促进疫苗的技术改良。 |
| 英文摘要: |
| Objective: To review the influence of regulatory policies on technical improvement of biological products for prevention taking the improvement of pertussis vaccine and human rabies vaccine as an example. Methods: The technical improvements in approved vaccines in China were analyzed through data analysis and literature research. Results: Technical improvement is an important means to promote the development of the vaccine industry. Conclusion: Regulatory authority should promote technical improvement of vaccines through policy guidance and encouragement. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |